Cargando…

Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis

OBJECTIVE: To evaluate the efficacy and feasibility of minimally invasive oblique lumbar interbody debridement and fusion for the treatment of conservatively ineffective lumbar spondylodiscitis. METHODS: This is a retrospective study. Between December 2016 and November 2017, a total of 14 consecutiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bingjin, Chen, Chao, Hua, Wenbin, Ke, Wencan, Lu, Saideng, Zhang, Yukun, Zeng, Xianlin, Yang, Cao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454224/
https://www.ncbi.nlm.nih.gov/pubmed/32524753
http://dx.doi.org/10.1111/os.12711
_version_ 1783575484217425920
author Wang, Bingjin
Chen, Chao
Hua, Wenbin
Ke, Wencan
Lu, Saideng
Zhang, Yukun
Zeng, Xianlin
Yang, Cao
author_facet Wang, Bingjin
Chen, Chao
Hua, Wenbin
Ke, Wencan
Lu, Saideng
Zhang, Yukun
Zeng, Xianlin
Yang, Cao
author_sort Wang, Bingjin
collection PubMed
description OBJECTIVE: To evaluate the efficacy and feasibility of minimally invasive oblique lumbar interbody debridement and fusion for the treatment of conservatively ineffective lumbar spondylodiscitis. METHODS: This is a retrospective study. Between December 2016 and November 2017, a total of 14 consecutive patients (eight males and six females, with an average age of 49.1 years, range from 42 to 74 years) with single‐level lumbar spondylodiscitis were included in the study. The inclusion criteria include single‐level spondylodiscitis without spinal deformity or epidural abscess, ineffective conservative treatment (continuously aggravated clinical symptoms and uncontrollable infective symptoms treated with antibiotics for more than 6 weeks), minimally invasive oblique lumbar interbody fusion surgery (Mis‐OLIF) and iliac graft for the treatment of lumbar spondylodiscitis, and postoperative follow‐up >12 months. Each patient was treated Mis‐OLIF. Clinical outcomes including demographic characteristics, erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), visual analog scale (VAS), the Oswestry Disability Index (ODI), American Spinal Injury Association neurological classification, and lordotic angle were analyzed. RESULTS: The infectious levels included L1/2 (one patient), L2/3 (two patients), L3/4 (eight patients), and L4/5 (three patients). The pathogens found in these patients included Staphylococcus aureus (5), brucellosis (6), and enterobacterium (2). The pathogen was undefined in one patient. The mean duration of the surgery, mean blood loss, and mean follow‐up were 89.3 ± 17.5 min, 155.0 ± 49.4 mL, and 16.8 ± 4.2 months, respectively. The ESR and CRP decreased after Mis‐OLIF and antibiotic administration. The average preoperative VAS score was 6.9 ± 0.9, then decreased to 3.0 ± 1.0 (t = 14.18, P < 0.001) and 0.6 ± 0.7 (t = 20.68, P < 0.001) before discharge and at final follow‐up, respectively. The average preoperative ODI score was 58.4 ± 13.0, then decreased to 28.3 ± 6.1 (t = 18.6, P < 0.001) and 8.0 ± 4.6 (t = 22.7, P < 0.001) before discharge and at final follow‐up, respectively. None of the patients developed postoperative ileus, vascular injury, nerve injury, and ureteral injury. One patient suffered incision‐related complication that healed by debridement and dressing change. One patient developed subsidence of autologous iliac bone before discharge and achieved complete bony fusion after staying in bed and fixing it with a brace at 3 months follow‐up. All patients achieved bony fusion at final follow‐up. CONCLUSION: Mis‐OLIF without anterior or posterior instrumentation and iliac graft is an effective and viable approach for the treatment of conservatively ineffective lumbar spondylodiscitis without spinal deformity or epidural abscess.
format Online
Article
Text
id pubmed-7454224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-74542242020-09-02 Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis Wang, Bingjin Chen, Chao Hua, Wenbin Ke, Wencan Lu, Saideng Zhang, Yukun Zeng, Xianlin Yang, Cao Orthop Surg Clinical Articles OBJECTIVE: To evaluate the efficacy and feasibility of minimally invasive oblique lumbar interbody debridement and fusion for the treatment of conservatively ineffective lumbar spondylodiscitis. METHODS: This is a retrospective study. Between December 2016 and November 2017, a total of 14 consecutive patients (eight males and six females, with an average age of 49.1 years, range from 42 to 74 years) with single‐level lumbar spondylodiscitis were included in the study. The inclusion criteria include single‐level spondylodiscitis without spinal deformity or epidural abscess, ineffective conservative treatment (continuously aggravated clinical symptoms and uncontrollable infective symptoms treated with antibiotics for more than 6 weeks), minimally invasive oblique lumbar interbody fusion surgery (Mis‐OLIF) and iliac graft for the treatment of lumbar spondylodiscitis, and postoperative follow‐up >12 months. Each patient was treated Mis‐OLIF. Clinical outcomes including demographic characteristics, erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), visual analog scale (VAS), the Oswestry Disability Index (ODI), American Spinal Injury Association neurological classification, and lordotic angle were analyzed. RESULTS: The infectious levels included L1/2 (one patient), L2/3 (two patients), L3/4 (eight patients), and L4/5 (three patients). The pathogens found in these patients included Staphylococcus aureus (5), brucellosis (6), and enterobacterium (2). The pathogen was undefined in one patient. The mean duration of the surgery, mean blood loss, and mean follow‐up were 89.3 ± 17.5 min, 155.0 ± 49.4 mL, and 16.8 ± 4.2 months, respectively. The ESR and CRP decreased after Mis‐OLIF and antibiotic administration. The average preoperative VAS score was 6.9 ± 0.9, then decreased to 3.0 ± 1.0 (t = 14.18, P < 0.001) and 0.6 ± 0.7 (t = 20.68, P < 0.001) before discharge and at final follow‐up, respectively. The average preoperative ODI score was 58.4 ± 13.0, then decreased to 28.3 ± 6.1 (t = 18.6, P < 0.001) and 8.0 ± 4.6 (t = 22.7, P < 0.001) before discharge and at final follow‐up, respectively. None of the patients developed postoperative ileus, vascular injury, nerve injury, and ureteral injury. One patient suffered incision‐related complication that healed by debridement and dressing change. One patient developed subsidence of autologous iliac bone before discharge and achieved complete bony fusion after staying in bed and fixing it with a brace at 3 months follow‐up. All patients achieved bony fusion at final follow‐up. CONCLUSION: Mis‐OLIF without anterior or posterior instrumentation and iliac graft is an effective and viable approach for the treatment of conservatively ineffective lumbar spondylodiscitis without spinal deformity or epidural abscess. John Wiley & Sons Australia, Ltd 2020-06-10 /pmc/articles/PMC7454224/ /pubmed/32524753 http://dx.doi.org/10.1111/os.12711 Text en © 2020 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Articles
Wang, Bingjin
Chen, Chao
Hua, Wenbin
Ke, Wencan
Lu, Saideng
Zhang, Yukun
Zeng, Xianlin
Yang, Cao
Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title_full Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title_fullStr Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title_full_unstemmed Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title_short Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis
title_sort minimally invasive surgery oblique lumbar interbody debridement and fusion for the treatment of lumbar spondylodiscitis
topic Clinical Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454224/
https://www.ncbi.nlm.nih.gov/pubmed/32524753
http://dx.doi.org/10.1111/os.12711
work_keys_str_mv AT wangbingjin minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT chenchao minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT huawenbin minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT kewencan minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT lusaideng minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT zhangyukun minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT zengxianlin minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis
AT yangcao minimallyinvasivesurgeryobliquelumbarinterbodydebridementandfusionforthetreatmentoflumbarspondylodiscitis